Carregant...
Mechanism of increased LDL and decreased triglycerides with SGLT2 inhibition
OBJECTIVE: Sodium glucose cotransporter 2 (SGLT2) inhibition in humans leads to increased levels of LDL cholesterol and decreased levels of plasma triglyceride. Recent studies however, have shown this therapy to lower cardiovascular mortality. In this study, we aimed to determine how SGLT2 inhibitio...
Guardat en:
| Publicat a: | Arterioscler Thromb Vasc Biol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207215/ https://ncbi.nlm.nih.gov/pubmed/30354257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.118.311339 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|